Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May-Aug;8(2):86-88.
doi: 10.1016/j.jobcr.2017.06.002. Epub 2017 Jun 19.

Conservative management of Oral Submucous Fibrosis in early and intermediate stage

Affiliations

Conservative management of Oral Submucous Fibrosis in early and intermediate stage

Sachin Rai et al. J Oral Biol Craniofac Res. 2018 May-Aug.

Abstract

Aims & objective: To evaluate the efficacy of combined intralesional injection of Hyaloronidase and Triamcinolone with third molar removal in early and intermediate stage (Stage II & III) of Oral Submucous Fibrosis (OSMF) for improvement in mouth opening and hypersensitivity to food.

Study design: 48 patients in stage II & III OSMF were selected for the study. All the third molars were extracted in each patient followed by 6-8 doses of combined intralesional injection of Hyaloronidase and triamcinolone at 10 days interval targeting the fibrotic bands. Mouth opening and improvement in hypersensitivity to food was noted by numerical grading. The patients were followed for one year at regular intervals. The data was expressed as mean ± SD, and a probability (p) value of <0.05 was considered significant.

Results: The initial mouth opening in Stage II patients (n = 27) was 30 ± 3.0 mm and in Stage III patients (n = 21) was 19 ± 3.5 mm and the increase in mouth opening at the end of treatment was 11.3 ± 1.9 mm and 10.2 ± 2.3 mm respectively. The mean improvement in hypersensitivity to food in both the groups was 2.9 and 2.2 respectively.

Conclusion: There is significant improvement in grade II patients in mouth opening and hypersensitivity to food. Grade III patients show variable improvement or no improvement wherein surgery becomes the only option. Third molar extraction helps in reducing inflammation and fibrosis in the retromolar region thus easing in mouth opening. This combined approach for moderately staged OSMF can be proposed as a viable conservative modality.

Keywords: Hyaluronidase; Oral Submucous Fibrosis; Third molar; Triamcinolone.

PubMed Disclaimer

References

    1. Malhotra D., Pradhan R., Gupta S. Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:e1–e10. - PubMed
    1. Khanna J.N., Andrade N.N. Oral submucous fibrosis—a new concept in surgical management. Int J Oral Maxillofac Surg. 1995;24:433–439. - PubMed
    1. Borle R.M., Borle S.M. Management of oral submucous fibrosis: a conservative approach. J Oral Maxollofac Surg. 1991;49:788–791. - PubMed
    1. Kumar A., Bagewadi A., Keluskar V., Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:207–209. - PubMed
    1. Rajendran V., Rani S., Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Ind J Dent Res. 2006;17(4):190–198. - PubMed

LinkOut - more resources